• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Transl Androl Urol . Evaluation of mid- and long-term impact of COVID-19 on male fertility through evaluating semen parameters

tetano

Editor, Senior Moderator
Transl Androl Urol


. 2022 Feb;11(2):159-167.
doi: 10.21037/tau-21-922.
Evaluation of mid- and long-term impact of COVID-19 on male fertility through evaluating semen parameters


Bintao Hu[SUP] #[/SUP][SUP] 1 2 [/SUP], Kang Liu[SUP] #[/SUP][SUP] 1 2 [/SUP], Yajun Ruan[SUP] 1 2 [/SUP], Xian Wei[SUP] 1 2 [/SUP], Yue Wu[SUP] 1 2 [/SUP], Huan Feng[SUP] 1 2 [/SUP], Zhiyao Deng[SUP] 1 2 [/SUP], Jihong Liu[SUP] 1 2 [/SUP], Tao Wang[SUP] 1 2 [/SUP]



Affiliations

Abstract

Background: The coronavirus disease 2019 (COVID-19) has spread worldwide with alarming levels of spread and severity. The distribution of angiotensin converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2) from bioinformatics evidence, the autopsy report for COVID-19 and the published study on sperm quality indicated COVID-19 could have a negative impact on male fertility. However, whether the negative impact of COVID-19 on male fertility is persistent remains unknown, which requires long-term follow-up investigation.
Methods: Semen samples were collected from 36 male COVID-19 patients with a median recovery time of 177.5 days and 45 control subjects. Then, analysis of sperm quality and alterations of total sperm number with recovery time were performed.
Results: There was no significant difference in semen parameters between male recovered patients and control subjects. And the comparisons of semen parameters between first follow-up and second follow-up revealed no significant difference. In addition, we explored the alterations of sperm count with recovery time. It showed that the group with recovery time of ≥120 and <150 days had a significantly lower total sperm number than controls while the other two groups with recovery time of ≥150 days displayed no significance with controls, and total sperm number showed a significant decline after a recovery time of 90 days and an improving trend after a recovery time of about 150 days.
Conclusions: The sperm quality of COVID-19 recovered patients improved after a recovery time of nearly half a year, while the total sperm number showed an improvement after a recovery time of about 150 days. COVID-19 patients should pay close attention to the quality of semen, and might be considered to be given medical interventions if necessary within about two months after recovery, in order to improve the fertility of male patients as soon as possible.

Keywords: Coronavirus disease 2019 (COVID-19); male fertility; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); sperm quality.
 
Back
Top Bottom